Response to: Comment on ’Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Zhu

Saved in:

Bibliographic Details
Main Authors:	Egbert F Smit, Willemijn S M E Theelen, Michiel M Smeenk, Vincent van der Noort, Hanieh Abedian Kalkhoran, Jeroen J M A Hendrikx
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-07-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/7/e012095.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet